ISDA

Entry Detail

PDB ID:

5IVS

Keywords:

Title:

Crystal Structure of HIV Protease complexed with methyl N-[(1S)-1-benzhydryl-2-[2-[2-[(2R,5S)-5-(benzylcarbamoyloxymethyl)morpholin-2-yl]ethyl]anilino]-2-oxo-ethyl]carbamate

Biological Source:

Source Organism:

Human immunodeficiency virus 1

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

2016-03-21

Release Date:

2016-05-18

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.46 Å

R-Value Free:

0.19

R-Value Work:

0.18

R-Value Observed:

0.18

Space Group:

P 21 21 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Protease
Chain IDs:A, B
Chain Length:99
Number of Molecules:2
Biological Source:Human immunodeficiency virus 1

UniProt ID:Q77VV3 Pfam ID:PF00077

Ligand Molecules

6EF

Primary Citation

Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding Group.

Bungard, C.J, Williams, P.D, Ballard, J.E, Bennett, D.J, Beaulieu, C, Bahnck-Teets, C, Carroll, S.S, Chang, R.K, Dubost, D.C, Fay, J.F, Diamond, T.L, Greshock, T.J, Hao, L, Holloway, M.K, Felock, P.J, Gesell, J.J, Su, H.P, Manikowski, J.J, McKay, D.J, Miller, M, Min, X, Molinaro, C, Moradei, O.M, Nantermet, P.G, Nadeau, C, Sanchez, R.I, Satyanarayana, T, Shipe, W.D, Singh, S.K, Truong, V.L, Vijayasaradhi, S, Wiscount, C.M, Vacca, J.P, Crane, S.N, McCauley, J.A.Show

Acs Med.Chem.Lett. 7 702 707 (2016)

PMID: 27437081 DOI: 10.1021/acsmedchemlett.6b00135

Abstact

A novel HIV protease inhibitor was designed using a morpholine core as the aspartate binding group. Analysis of the crystal structure of the initial lead bound to HIV protease enabled optimization of enzyme potency and antiviral activity. This afforded a series of potent orally bioavailable inhibitors of which MK-8718 was identified as a compound with a favorable overall profile.

Legend

Protein

Chemical

Disease

Primary Citation of related structures